BridgeBio Pharma BBIO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$166.56M+14.4% | -$194.64M-5.2% | -$184.94M-0.6% | -$183.76M-8.3% | -$169.61M+36.6% | ||
| $1.19M-17.4% | $1.44M+2.6% | $1.4M+6.2% | $1.32M+2.6% | $1.28M-6.1% | ||
| $33.24M-4.0% | $34.64M-1.8% | $35.26M-5.3% | $37.24M+43.9% | $25.88M-14.1% | ||
| -$197.28M-250% | -$56.42M+48.5% | -$109.57M-35.8% | -$80.68M+59.5% | -$199.24M-2.0% | ||
| $69K+109% | $33K-93.0% | $470K-20.9% | $594K— | $0-100% | ||
| -$42.74M-198% | -$14.35M— | —— | -$13M-715% | -$1.6M— | ||
| $82.5M— | —— | —— | —— | $48.28M— | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | $459M— | ||
| $549.89M— | —— | —— | $302.04M+401% | $60.33M-87.3% | ||
| $309.88M+525% | -$72.96M+31.2% | -$106M-151% | $208.36M+248% | -$140.5M-151% | ||
| -$197.35M-250% | -$56.45M+48.7% | -$110.04M-35.4% | -$81.28M+59.2% | -$199.24M-2.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BridgeBio Pharma generate?
- BridgeBio Pharma (BBIO) generated -$444.0M in operating cash flow over the trailing twelve months.
- What is BridgeBio Pharma's free cash flow?
- After $1.2M of capital expenditures, BridgeBio Pharma's free cash flow was -$445.1M over the trailing twelve months, up 44.0% year over year.
- Where does BridgeBio Pharma's cash flow data come from?
- Every line is extracted from BridgeBio Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
